Comentario editorial sobre carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México

by C. Moctezuma-Velázquez
Published 2021-01-01

Editorial comment on hepatocellular carcinoma in the noncirrhotic liver: Clinical characteristics and results in Veracruz, Mexico

by C. Moctezuma-Velázquez
Published 2021-01-01

Current treatment for non-alcoholic fatty liver disease

by C. Moctezuma-Velázquez
Published 2018-04-01

Tratamiento actual de la enfermedad por hígado graso no alcohólico

by C. Moctezuma-Velázquez
Published 2018-04-01

Characteristics of the overlap syndrome (HAI / CBP, HAI / CEP): a cohort type study in a reference center in Mexico during the period 2008–2018

by A. Vélez Carrión, C. Moctezuma Velázquez, A. Torre Delgadillo
Published 2020-09-01

Clinical, demographic, radiological and histological features of a series of liver adenomas in a reference hospital

by F.C. Thomas Lora, A. Torre Delgadillo, C. Moctezuma Velázquez
Published 2020-09-01

Giant hepatic hemangioma versus conventional hepatic hemangioma: Clinical findings, risk factors, and management

by C. Moctezuma-Velázquez, G. López-Arce, L.A. Martínez-Rodríguez, C. Escalona-Huerta, M. Chapa-Ibargüengoitia, A. Torre
Published 2014-10-01

Hemangioma hepático gigante versus hemangioma hepático convencional: características clínicas, factores de riesgo y manejo

by C. Moctezuma-Velázquez, G. López-Arce, L.A. Martínez-Rodríguez, C. Escalona-Huerta, M. Chapa-Ibargüengoitia, A. Torre
Published 2014-10-01

Manejo farmacológico de pacientes con enfermedades hepáticas y pancreáticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVI...

by G. Miranda-Zazueta, J.A. González-Regueiro, I. García-Juárez, C. Moctezuma-Velázquez, F.J. López-Díaz, B. Pérez-González, L.F. Uscanga-Domínguez, M. Peláez-Luna
Published 2020-07-01

Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pa...

by G. Miranda-Zazueta, J.A. González-Regueiro, I. García-Juárez, C. Moctezuma-Velázquez, F.J. López-Díaz, B. Pérez-González, L.F. Uscanga-Domínguez, M. Peláez-Luna
Published 2020-07-01

Characterization of patients with primary sclerosing cholangitis in a third level hospital

by V. López Ladrón de Guevara, C. Alonzo García, A. Vélez Carrión, F. Thomas Lora, B. Astudillo Romero, E. Márquez Guillén, C. Moctezuma Velázquez, N.C. Flores García, G. Castro Narro, A. Torre Delgadillo
Published 2020-09-01